Targeting RuvBL1 disrupts mitochondrial metabolism and structure in hepatocellular carcinoma
Tommaso Mello(University of Florence), Andrea Galli(University of Florence), Daniele Guasti(University of Florence), Alice Guida(University of Florence), Oxana Bereshchenko(University of Perugia), E. Ceni(University of Florence), I. Simeone(University of Florence), Alice Santi(European Society for Sexual Medicine), Simone Polvani(University of Florence), Dimitri Papini(University of Florence), Massimo Bonora(University of Ferrara), Matteo Lulli(University of Florence), Patrizia Nardini(University of Florence), Francesca Begnozzi(University of Ferrara), Paolo Pinton(University of Ferrara), Armando Curto(University of Florence)
Cited by 0
Related Papers
Morin: A Promising Natural Drug
|Current Medicinal Chemistry|2016|249
Cancer Associated Fibroblasts: The Architects of Stroma Remodeling
|PROTEOMICS|2017|247
Tumor matrix stiffness promotes metastatic cancer cell interaction with the endothelium
|The EMBO Journal|2017|201
Coenzyme Q10 Instilled as Eye Drops on the Cornea Reaches the Retina and Protects Retinal Layers from Apoptosis in a Mouse Model of Kainate-Induced Retinal Damage
|Investigative Ophthalmology & Visual Science|2012|155
The insulin-mimetic effect of Morin: A promising molecule in diabetes treatment
|Biochimica et Biophysica Acta (BBA) - General Subjects|2013|134